Improvements in Skin and Nail Psoriasis are Positively Correlated across Systemic Psoriasis Therapies
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 2
Abstract
Objective: For clinical scenarios where patients have moderate to severe psoriasis and nail psoriasis, knowing whether skin response is correlated with nail response would provide insight into the relationship between psoriatic skin and nail unit inflammation. The primary objective of this study was to determine if improvement in skin and nail psoriasis across a range of systemic therapies are correlated. Methods: Relevant publications pertaining to systemic therapies approved in the US for psoriasis were identified via PubMed search. Only studies with placebo controls were included. The paired point estimates of the PASI 75 response treatment effect [i.e., the placebo-adjusted PASI 75 response rate] (independent variable) and mean percentage NAPSI improvement for target fingernail treatment effect [also placebo-adjusted] (dependent variable) were calculated for each therapy. Simple linear regression analysis weighted by the standard errors for the independent and dependent variables was performed. Results: Ten paired treatment effects for 4 systemic therapies (apremilast, adalimumab, etanercept, and guselkumab) were obtained. Guselkumab and adalimumab were associated with the greatest nail improvement, and guselkumab was associated with the greatest skin response rate. PASI 75 response rate and mean percentage improvement target fingernail NAPSI were positively correlated (p=0.03), with an R2 value of 0.48. Conclusions: There is significant positive correlation across different therapies between the magnitude of improvement in psoriatic skin and nail disease among patients with moderate-severe psoriasis and clinically significant nail disease.
Authors and Affiliations
Thomas SD Okun, Martin M Okun
Keywords
Related Articles
- EP ID EP717027
- DOI https://doi.org/10.46889/JDR.2023.4203
- Views 63
- Downloads 0
Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison of a Single Dose of Super-bioavailable Itraconazole 130 mg and Innovator SUBA®-Itraconazole Capsules 130 mg (2 x 65 mg) in Healthy Adults Under Fed Conditions
Introduction: Itraconazole (ITZ), an antifungal agent taken orally, demonstrates intricate and variable absorption kinetics, significantly impacted by food intake. The invention of Super-Bioavailable Itraconazole (SITZ)...
Radiofrequency Current at 448 Khz For Female Pattern Hair Loss: Cellular Bases For Redensification Improvement
Objective: Capacitive-Resistive Electrothermal Therapies (CRET) have proven effective in tissue regeneration. This study analyzes the response to 448-kHz CRET treatment in 20 patients with Female Pattern Hair Loss (FPHL)...
The Applications of Fractional Lasers in Taiwan
The applications of fractional lasers are enormous. In Taiwan, the most commonly used fractional lasers can be divided into 3 different categories: ablative, non-ablative, and combined hybrid laser. The ablative fracti...
Isotopic Phenomenon: Case Report and Distinctions Between the Isomorphic Phenomenon, Inverse Isomorphic Phenomenon and the Sign of Pathergy
The isotope phenomenon, also called the Wolf’s isotopic response, refers to the emergence of a new skin disease at the exact location of a previously cured unrelated skin disease, often following infection with the herpe...
Sézary Syndrome as an Etiological Cause of Erythroderma: A Case Report
Exfoliative erythroderma is a syndrome characterized by erythema and scaling that affects more than 90% of the body surface. In contrast, Sézary Syndrome is a rare and harmful variant of cutaneous T-cell lymphoma, define...